The Generic Pharmaceutical Association (GPhA) President and CEO Chip Davis released a statement last week regarding President Obama's final State of the Union Address, specifically about his remarks on ending cancer. Read More »
Chip Davis, president and CEO of the Generic Pharmaceutical Association (GPhA), announced this week that Dr. Robert Califf has received enough votes from the Senate Committee on Health, Education Labor and Pensions (HELP) in favor of his nomination as the new commissioner of the Food and Drug Administration (FDA). Read More »
A new federal initiative announced by the Medicare Accountable Care Organization (ACO) will make the quality of care for patients more important than quantity of procedures administered. Read More »
In the next eight years, pharmacists’ employment is only expected to grow 3 percent in the United States, according to the Bureau of Labor Statistics. Read More »
In response to the U.S. Senate Special Committee on Aging's hearing on "Sudden Price Spikes in Off-Patent Prescription Drugs" held earlier this month, Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt asked policymakers to take an initiative toward making generic drugs easier to produce and distribute. Read More »
While the Biosimilars Council, a division of the Generic Pharmaceutical Association (GPhA), applauds the Food and Drug Administration's (FDA) current discussions on the next Biosimilar User Fee Act (BsUFA), it hopes to collaborate even more with the FDA on biosimilar medications. Read More »
While approximately 6 million Americans have either re-enrolled or signed up for health coverage for the first time through the Health Insurance Marketplace so far, the Department of Health and Human Services (HHS) has partnered with several pharmacies around the nation to encourage even more individuals to sign up. Read More »
The Department of Health and Human Services (HHS) is collaborating with numerous national grocery and retail stores to provide consumers with health coverage through the Health Insurance Marketplace. Read More »
A recent hearing of the U.S. Senate Special Committee on Aging in Washington, D.C., discussed price increases on non-patented prescription drugs. Read More »
The U.S. Senate Special Committee on Aging met on Dec. 9 to hear testimony regarding the recent spike in prices for off-patent prescription drugs. Read More »
Following this week’s U.S. Senate Special Committee on Aging's hearing on "Sudden Price Spikes in Off-Patent Prescription Drugs," Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt called for this nation’s policymakers to make generic drugs more accessible. Read More »
The House Judiciary Subcommittee is looking to examine whether pharmacy benefit management (PBM) tools will lower the cost of prescription drugs. Read More »
The Generic Pharmaceutical Association (GPhA) named Chris Bowlin as the consortium’s senior vice president of Government Affairs Tuesday. Read More »
At the recent Health and Human Services Convention, the increased competition of drugs and the elimination of delays on drug approvals were discussed to improve patient access to drugs and lower costs. Read More »
The Center for American Progress (CAP) recently submitted a proposal to improve Medicare by offering transparency in drug costs while reducing costs for consumers. Read More »
The American College of Cardiology held a roundtable Oct. 24 to discuss health care issues and anticoagulation management. Read More »
A federal court recently denied a motion from the state of Arkansas to dismiss a lawsuit brought by the Pharmaceutical Care Management Association (PCMA) that challenges the legality of Arkansas 900. Read More »
Elsevier will be the publisher of all American Pharmacists Association (APhA) publications starting Jan. 1. Read More »
A report released Tuesday by the Generic Pharmaceutical Association (GPhA) indicates generic drugs generated significant savings for all stakeholders in the health care industry in 2014 and over the past decade. Read More »
The U.S. Department of Health and Human Services Office of Inspector General said recently the federal Medicaid program could have realized savings if New York had applied medical loss ratio standards like those set in the Affordable Care Act (ACA). Read More »
Alerts Sign-up
